Apriem Advisors’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-200
Closed -$13K 405
2018
Q2
$13K Buy
+200
New +$11.5K ﹤0.01% 393
2017
Q2
Sell
-250
Closed -$16K 582
2017
Q1
$16K Hold
250
﹤0.01% 374
2016
Q4
$13K Hold
250
﹤0.01% 419
2016
Q3
$14K Sell
250
-350
-58% -$16.6K ﹤0.01% 372
2016
Q2
$24K Buy
600
+350
+140% +$13.3K 0.01% 315
2016
Q1
$9K Hold
250
﹤0.01% 393
2015
Q4
$11K Hold
250
﹤0.01% 369
2015
Q3
$10K Hold
250
﹤0.01% 366
2015
Q2
$12K Hold
250
﹤0.01% 400
2015
Q1
$9K Hold
250
﹤0.01% 425
2014
Q4
$8K Hold
250
﹤0.01% 398
2014
Q3
$9K Buy
250
+150
+150% +$5.9K ﹤0.01% 390
2014
Q2
$4K Hold
100
﹤0.01% 412
2014
Q1
$5K Hold
100
﹤0.01% 412
2013
Q4
$4K Buy
+100
New +$4.08K ﹤0.01% 434

Other funds holding SGEN

Apriem Advisors's SGEN Position: Q3 2018 in Review

Apriem Advisors sold out of Seagen Inc. Common Stock (SGEN) in Q3 2018, closing a stake of 200 shares — an estimated $13K sold.

Apriem Advisors first reported a position in SGEN in Q4 2013 and held it in 15 quarters. The position peaked at $24K in Q2 2016. 330 funds tracked by Wall St. Rank hold SGEN as of Q3 2018.

  • Apriem Advisors reported no remaining Seagen Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
  • Apriem Advisors sold 200 Seagen Inc. Common Stock shares in Q3 2018, an estimated $13K.
  • Apriem Advisors first reported a position in Seagen Inc. Common Stock in Q4 2013 and held it in 15 quarters.
  • Apriem Advisors's Seagen Inc. Common Stock position peaked at $24K in Q2 2016.
  • 330 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q3 2018.

Based on Apriem Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.